Vast in-house database for rapid feasibility assessment of potential patient numbers for a given study.
Real world evidence (RWE) based on access to > 100,000 patients is one of the key offerings of 4MCS, with loyalty being an important factor to our success.
4MCS understands the complexity of drug development and clinical research activities. With ever-changing regulatory environments, the development of new medicines and/or new indications brings about unique challenges.
4MCS has decades of experience in clinical trial programmes from initial concepts to completing phase 2-4 clinical researches and dossier submissions for marketing authorisation.